Seth joined Novartis in 2004 as a Global Brand Communications Manager supporting the Diovan business. He moved through a number of roles in both Sales and Marketing during his next 12 years with the company. Most recently, Seth has successfully expanded the Oncology portfolio—launching Cyclophosphamide and Levoleucovorin. In addition, last December, he launched a direct integrated delivery network (IDN) sales force stimulating hospital and clinic demand.
Seth assumed the role of Vice President, Oncology & Injectables, in November 2016 where he is responsible for the development, adaptation and implementation of the portfolio strategy for oncology and injectable products at Sandoz. This includes the management of the product life cycle from development, launch and commercialization and through to product discontinuations. Seth received his MBA from Columbia University and his undergraduate degree from the University of Iowa.
EVENTS & ACTIVITIES (Speaking, Spoken, and Authored)